Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA TC Combination Therapy in Participants With Cystic Fibrosis Who Are 6 Years of Age and Older
Clinical trial NCT04183790 · COMPLETED
Trial details
- NCT number
- NCT04183790
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-17
- Primary completion
- 2024-02-24
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.